British drugmaker GlaxoSmithKline (GSK) on Monday (British time) announced that Emma Walmsley will step down as chief executive in January after nearly nine years at the helm, making way for chief ...

GSK lifted profit expectations for the year on Wednesday after the pharmaceutical group's sales were boosted by bumper demand for HIV and cancer drugs in the third quarter. It comes as boss Emma ...

GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is ...

GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.  | GSK is ...

Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...

British drugmaker GSK said on Tuesday it will invest £400 ​million ($531 million) over three years in the country, including moving ‌its R&D operations to Cambridge, as part of its plans to develop ...

LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker will aim to lift sales growth and speed up work on new medicines in its next ‌phase of growth through a sharper ...